Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;197(3):266-268.
doi: 10.1007/s00066-020-01735-4. Epub 2021 Jan 5.

[The PORTEC-3 trial for high-risk endometrial cancer: impact of molecular classification on prognosis and benefit from adjuvant therapy]

[Article in German]
Simone Marnitz  1   2 , Birgid Schömig-Markiefka  3   4
Affiliations
Comment

[The PORTEC-3 trial for high-risk endometrial cancer: impact of molecular classification on prognosis and benefit from adjuvant therapy]

[Article in German]
Simone Marnitz et al. Strahlenther Onkol. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

Literatur

    1. de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB et al (2018) Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 19:295–309 - DOI
    1. Leon-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, Nijman HW et al (2020) Molecular classification of the PORTEC‑3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy. J Clin Oncol 38:3388–3397 - DOI
    1. Raffone A, Travaglino A, Mascolo M, Carbone L, Guida M, Insabato L, Zullo F (2019) TCGA molecular groups of endometrial cancer: pooled data about prognosis. Gynecol Oncol 155:374–383 - DOI
    1. Marnitz S, Waltar T, Köhler C, Mustea A, Schömig-Markiefka B (2020) The brave new world of endometrial cancer: future implications for adjuvant treatment decisions. Strahlenther Onkol 196:963–972 - DOI
    1. Marnitz S, Walter T, Schömig-Markiefka B, Engler T, Kommoss S, Brucker SY (2020) A modern approach to endometrial carcinoma: Will molecular classification improve precision medicine in the future? Cancers (Basel) 12(9):2577 - DOI

LinkOut - more resources